Evidence map›Paper›PMID 25830351›Full record

ArticlePloS one2015

Risk factors for Plasmodium falciparum gametocyte positivity in a longitudinal cohort.

Laura Grange, Cheikh Loucoubar, Olivier Telle, Adama Tall, Joseph Faye, Cheikh Sokhna, Jean-François Trape, Anavaj Sakuntabhai, Jean-François Bureau, Richard Paul

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Biology and epidemiology ofParasite epidemiology and control · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Laura GrangeInstitut Pasteur, Unité de la Génétique Fonctionnelle des Maladies Infectieuses, 28 rue du Docteur Roux, F-75724 Paris cedex 15, France; Centre National de la Recherche Scientifique, URA3012, F-75015 Paris, France.
Cheikh LoucoubarInstitut Pasteur, Unité de la Génétique Fonctionnelle des Maladies Infectieuses, 28 rue du Docteur Roux, F-75724 Paris cedex 15, France; Centre National de la Recherche Scientifique, URA3012, F-75015 Paris, France; Institut Pasteur de Dakar, Unité d'Epidémiologie des Maladies Infectieuses (UR 172), Dakar, Senegal.
Olivier TelleInstitut Pasteur, Unité de la Génétique Fonctionnelle des Maladies Infectieuses, 28 rue du Docteur Roux, F-75724 Paris cedex 15, France; Centre National de la Recherche Scientifique, URA3012, F-75015 Paris, France.
Adama TallInstitut Pasteur de Dakar, Unité d'Epidémiologie des Maladies Infectieuses (UR 172), Dakar, Senegal.
Joseph FayeInstitut Pasteur de Dakar, Unité d'Epidémiologie des Maladies Infectieuses (UR 172), Dakar, Senegal.
Cheikh SokhnaInstitut de Recherche pour le Développement, Dakar, Unité de Pathogénie Afro-Tropicale (UMR 198), Senegal.
Jean-François TrapeInstitut de Recherche pour le Développement, Dakar, Unité de Pathogénie Afro-Tropicale (UMR 198), Senegal.
Anavaj SakuntabhaiInstitut Pasteur, Unité de la Génétique Fonctionnelle des Maladies Infectieuses, 28 rue du Docteur Roux, F-75724 Paris cedex 15, France; Centre National de la Recherche Scientifique, URA3012, F-75015 Paris, France.
Jean-François BureauInstitut Pasteur, Unité de la Génétique Fonctionnelle des Maladies Infectieuses, 28 rue du Docteur Roux, F-75724 Paris cedex 15, France; Centre National de la Recherche Scientifique, URA3012, F-75015 Paris, France.
Richard PaulInstitut Pasteur, Unité de la Génétique Fonctionnelle des Maladies Infectieuses, 28 rue du Docteur Roux, F-75724 Paris cedex 15, France; Centre National de la Recherche Scientifique, URA3012, F-75015 Paris, France.
Centre National de la Recherche Scientifique · FRInstitut Pasteur de Dakar · SNInstitut de Recherche pour le Développement · SN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria transmission intensity is highly heterogeneous even at a very small scale. Implementing targeted intervention in malaria transmission hotspots offers the potential to reduce the burden of disease both locally and in adjacent areas. Transmission of malaria parasites from man to mosquito requires the production of gametocyte stage parasites. Cluster analysis of a 19-year long cohort study for gametocyte carriage revealed spatially defined gametocyte hotspots that occurred during the time when chloroquine was the drug used for clinical case treatment. In addition to known risk factors for gametocyte carriage, notably young age (<15 years old) and associated with a clinical episode, blood groups B and O increased risk compared to groups A and AB. A hotspot of clinical P. falciparum clinical episodes that overlapped the gametocyte hotspots was also identified. Gametocyte positivity was found to be increased in individuals who had been treated with chloroquine, as opposed to other drug treatment regimens, for a clinical P. falciparum episode up to 30 days previously. It seems likely the hotspots were generated by a vicious circle of ineffective treatment of clinical cases and concomitant gametocyte production in a sub-population characterized by an increased prevalence of all the identified risk factors. While rapid access to treatment with an effective anti-malarial can reduce the duration of gametocyte carriage and onward parasite transmission, localised hotspots represent a challenge to malaria control and eventual eradication.

Indexed as

Life Cycle StagesAdolescentChildChild, PreschoolCluster AnalysisHumansLongitudinal StudiesMalaria, FalciparumMultivariate AnalysisPlasmodium falciparumPrevalenceRisk FactorsSenegal

Identifiers

PMID25830351
PMCPMC4382284
OpenAlexW1976107049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.